Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Types
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Israel Gynecology Drugs Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value & Volume
5.2. Market Share & Forecast
5.2.1. By Therapeutics (Non-Hormonal Therapy vs Hormonal Therapy)
5.2.2. By Indication (Contraception, Gynecology infections, Female infertility, Postmenopausal Disorders, Polycystic Ovary Syndrome, Gynecology Cancer, Endometriosis)
5.2.3. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies Online Pharmacies)
5.2.4. By Region
5.2.5. By Company (2022)
5.3. Product Market Map
5.3.1. By Therapeutics
5.3.2. By Indication
5.3.3. By Distribution Channel
6. Israel Non-Hormonal Therapy Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Indication
6.2.2. By Distribution Channel
7. Israel Hormonal Therapy Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Indication
7.2.2. By Distribution Channel
8. Market Dynamics
8.1. Drivers
8.2. Challenges
9. Market Trends & Developments
9.1. Recent Development
9.2. Mergers & Acquisitions
9.3. Product Launches
10. Policy & Regulatory Landscape
11. Porters Five Forces Analysis
11.1. Competition in the Industry
11.2. Potential of New Entrants
11.3. Power of Suppliers
11.4. Power of Customers
11.5. Threat of Substitute Products
12. Israel Economic Profile
13. Competitive Landscape
13.1. Business Overview
13.2. Product Offerings
13.3. Recent Developments
13.4. Financials (As Reported)
13.5. Key Personnel
13.6. SWOT Analysis
13.6.1. Teva Pharmaceutical Industries Ltd.
13.6.2. Pfizer Inc.
13.6.3. GlaxoSmithKline plc
13.6.4. AstraZeneca Israel
13.6.5. Johnson & Johnson
13.6.6. Bayer Israel Ltd.
13.6.7. Abbott Laboratories Ltd.
13.6.8. Eli Lilly Israel Ltd.
13.6.9. AbbVie Inc.
13.6.10. OCON Medical
14. Strategic Recommendations
15. About Us & Disclaimer